Understanding the role of bacterial and fungal infection in COVID-19.
作者信息
Rawson Timothy M, Wilson Richard C, Holmes Alison
机构信息
National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, United Kingdom; Centre for Antimicrobial Optimization (CAMO), Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, United Kingdom.
National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, United Kingdom; Centre for Antimicrobial Optimization (CAMO), Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, United Kingdom.
出版信息
Clin Microbiol Infect. 2021 Jan;27(1):9-11. doi: 10.1016/j.cmi.2020.09.025. Epub 2020 Oct 9.
Abstract
摘要
相似文献
1
Understanding the role of bacterial and fungal infection in COVID-19.了解细菌和真菌感染在新冠病毒病中的作用。
Clin Microbiol Infect. 2021 Jan;27(1):9-11. doi: 10.1016/j.cmi.2020.09.025. Epub 2020 Oct 9.
2
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.细菌和真菌合并感染冠状病毒的个体：一项支持 COVID-19 抗菌药物处方的快速综述。
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. doi: 10.1093/cid/ciaa530.
3
Fungal superinfection in patients with COVID-19: Role of antifungal stewardship?新型冠状病毒肺炎患者的真菌二重感染：抗真菌管理的作用？
Am J Infect Control. 2021 Feb;49(2):279-280. doi: 10.1016/j.ajic.2020.11.015. Epub 2020 Nov 19.
4
Difference in the impact of coinfections and secondary infections on antibiotic use in patients hospitalized with COVID-19 between the Omicron-dominant period and the pre-Omicron period.奥密克戎变异株主导期与奥密克戎变异株流行前期新冠病毒感染者住院期间合并感染和继发感染对抗生素使用影响的差异。
J Infect Chemother. 2024 Sep;30(9):853-859. doi: 10.1016/j.jiac.2024.02.026. Epub 2024 Feb 28.
5
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.COVID-19 住院患者合并感染和再感染的发生率：一项回顾性队列研究。
Clin Microbiol Infect. 2021 Jan;27(1):83-88. doi: 10.1016/j.cmi.2020.07.041. Epub 2020 Jul 31.
6
Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future?在 COVID-19 时代，抗菌药物管理不善：人类是否正面临后抗生素时代？
Future Microbiol. 2021 Aug;16:919-925. doi: 10.2217/fmb-2021-0008. Epub 2021 Jul 28.
7
Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.苏格兰医院疑似和确诊 COVID-19 患者的抗生素和抗真菌药物处方调查。
J Infect. 2020 Dec;81(6):952-960. doi: 10.1016/j.jinf.2020.09.024. Epub 2020 Sep 26.
8
Increased antimicrobial resistance during the COVID-19 pandemic.新冠疫情期间抗菌药物耐药性增加。
Int J Antimicrob Agents. 2021 Apr;57(4):106324. doi: 10.1016/j.ijantimicag.2021.106324. Epub 2021 Mar 19.
9
Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.COVID-19 患者合并细菌感染和抗菌药物使用情况：抗生素管理视角下的回顾性队列研究。
Eur J Clin Microbiol Infect Dis. 2021 Apr;40(4):859-869. doi: 10.1007/s10096-020-04063-8. Epub 2020 Nov 2.
10
Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: A cohort study in Shanghai.评价 COVID-19 患者中的超级感染、抗菌药物使用和气道微生物组与宏基因组测序：上海的一项队列研究。
J Microbiol Immunol Infect. 2021 Oct;54(5):808-815. doi: 10.1016/j.jmii.2021.03.015. Epub 2021 Apr 6.
引用本文的文献
1
Healthcare-Associated Infections Secondary to Multidrug-Resistant Organisms in Hospitalised Patients with COVID-19 Pneumonia: .新型冠状病毒肺炎住院患者中多重耐药菌引起的医疗相关感染：
Sultan Qaboos Univ Med J. 2025 May 2;25(1):186-190. doi: 10.18295/2075-0528.2826.
2
The burden of nosocomial superinfections in a retrospective cohort study of critically ill COVID-19 patients.一项针对危重症COVID-19患者的回顾性队列研究中医院获得性二重感染的负担
BMC Infect Dis. 2025 May 3;25(1):650. doi: 10.1186/s12879-025-10983-7.
3
Antibiotic Utilization and Resistance According to the WHO AWaRe Classification in Intensive Care Units After COVID-19 Third Wave in Pakistan: Findings and Implications.巴基斯坦新冠疫情第三波后重症监护病房中基于世界卫生组织AWaRe分类的抗生素使用与耐药性：研究结果与启示
Medicina (Kaunas). 2025 Mar 10;61(3):481. doi: 10.3390/medicina61030481.
4
Genome-Wide Exploration of Thiamin Pyrophosphate Riboswitches in Medically Relevant Fungi Reveals Diverse Distribution and Implications for Antimicrobial Drug Targeting.医学相关真菌中硫胺素焦磷酸核糖开关的全基因组探索揭示了其多样分布及对抗菌药物靶向的意义。
ACS Omega. 2024 Dec 10;9(51):50134-50146. doi: 10.1021/acsomega.4c00158. eCollection 2024 Dec 24.
5
Bacterial co-infection in COVID-19: a call to stay vigilant.新冠病毒感染中的细菌合并感染：保持警惕的呼吁。
PeerJ. 2024 Sep 19;12:e18041. doi: 10.7717/peerj.18041. eCollection 2024.
6
Fungal coinfection/superinfection in COVID-19 patients in a tertiary hospital in Mexico.墨西哥一家三级医院 COVID-19 患者的真菌感染/合并感染。
Biomedica. 2024 Aug 29;44(3):328-339. doi: 10.7705/biomedica.7251.
7
The long Pentraxin PTX3 serves as an early predictive biomarker of co-infections in COVID-19.长型 Pentraxin PTX3 可作为 COVID-19 合并感染的早期预测性生物标志物。
EBioMedicine. 2024 Jul;105:105213. doi: 10.1016/j.ebiom.2024.105213. Epub 2024 Jun 21.
8
An Experience in Laboratory Diagnosis of Fungal Infections in COVID -19 Patients.新型冠状病毒肺炎患者真菌感染的实验室诊断经验
Int Arch Otorhinolaryngol. 2023 Sep 26;28(2):e180-e187. doi: 10.1055/s-0043-1768140. eCollection 2024 Apr.
9
The Rapidly Changing Patterns in Bacterial Co-Infections Reveal Peaks in Limited Gram Negatives during COVID-19 and Their Sharp Drop Post-Vaccination, Implying Potential Evolution of Co-Protection during Vaccine-Virus-Bacterial Interplay.细菌合并感染模式的快速变化揭示了 COVID-19 期间有限的革兰氏阴性菌的峰值及其接种疫苗后的急剧下降，这意味着在疫苗-病毒-细菌相互作用期间，合并保护可能会发生进化。
Viruses. 2024 Jan 31;16(2):227. doi: 10.3390/v16020227.
10
Prevalence, predictors, and outcome of pulmonary mucormycosis in COVID-19 associated rhino orbital mucormycosis in a tertiary care center in South India.印度南部一家三级护理中心中，新冠病毒相关鼻眶毛霉病患者的肺部毛霉病患病率、预测因素及预后情况
Curr Med Mycol. 2023 Sep;9(3):33-37. doi: 10.22034/cmm.2023.345154.1486.
本文引用的文献
1
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.COVID-19 住院患者合并感染和再感染的发生率：一项回顾性队列研究。
Clin Microbiol Infect. 2021 Jan;27(1):83-88. doi: 10.1016/j.cmi.2020.07.041. Epub 2020 Jul 31.
2
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.COVID-19 患者的细菌合并感染和继发感染：一项实时快速综述和荟萃分析。
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. doi: 10.1016/j.cmi.2020.07.016. Epub 2020 Jul 22.
3
Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis.应对和减轻 COVID-19 相关肺曲霉病的风险。
Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.02554-2020. Print 2020 Oct.
4
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.COVID-19 住院患者的细菌和真菌感染：英国二级保健机构中的回顾性队列研究。
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27.
5
Bacterial Pneumonia in COVID-19 Critically Ill Patients: A Case Series.新型冠状病毒肺炎危重症患者的细菌性肺炎：病例系列
Clin Infect Dis. 2021 Mar 1;72(5):905-906. doi: 10.1093/cid/ciaa762.
6
Antimicrobial use, drug-resistant infections and COVID-19.抗菌药物使用、耐药菌感染与新冠病毒。
Nat Rev Microbiol. 2020 Aug;18(8):409-410. doi: 10.1038/s41579-020-0395-y.
7
Co-infections in people with COVID-19: a systematic review and meta-analysis.COVID-19 患者合并感染：系统评价和荟萃分析。
J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27.
8
COVID-19 and the potential long-term impact on antimicrobial resistance.COVID-19 与潜在的长期抗菌药物耐药性影响
J Antimicrob Chemother. 2020 Jul 1;75(7):1681-1684. doi: 10.1093/jac/dkaa194.
9
COVID-19: don't neglect antimicrobial stewardship principles!2019冠状病毒病：勿忽视抗菌药物管理原则！
Clin Microbiol Infect. 2020 Jul;26(7):808-810. doi: 10.1016/j.cmi.2020.04.024. Epub 2020 Apr 30.
10
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.细菌和真菌合并感染冠状病毒的个体：一项支持 COVID-19 抗菌药物处方的快速综述。
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. doi: 10.1093/cid/ciaa530.
Zotero 插件